Antibiotics
Catalog | Product Name / CAS / Description | Structure |
---|---|---|
BBF-03317 | ||
OM-173βE is a quinone bacterial metabolite originally isolated from Streptomyces hebeiensis, displaying antimicrobial activity. It is effective against mycoplasma and fungus. |
||
BBF-03318 | ||
OM-173αB is a quinone bacterial metabolite originally isolated from Streptomyces hebeiensis, displaying antimicrobial activity. It is effective against mycoplasma and fungus. |
||
BBF-03321 | ||
P-132 is an antibiotic produced by Microbispora P-132, W-17 and 37-26. It is effective against gram-positive bacteria, fungi and actinomycetes. |
||
BBF-03323 | ||
P-2563 III is an antibiotic produced by Pseudomonas fluorescens P-2563. It is effective against gram-positive and gram-negative bacteria, especially against Pseudomonas. |
||
BBF-03324 | ||
P-3355 is antibacterial and antifungal antibiotic produced by streptomyces amylovorus. |
||
BBF-03325 |
PA-1329-E1 (80860-79-3) Inquiry |
|
PA-1329-E1 is a nucleoside antibiotic produced by Micromonospora sp. PA-1329. It exhibits activity against Candida albicans. |
||
BBF-03326 | ||
PA-31088-II is a carbapenem antibiotic produced by Streptomyces tokunonensis PA-31088 and Str. argenteolus PA-39504. |
||
BBF-03327 |
PA-46101 A (130743-11-2) Inquiry |
|
PA-46101 A is a macrolide antibiotic isolated from the culture broth of Streptomyces sp. PA-46101. It is active in vitro against anaerobic Gram-positive and Gram-negative bacteria and also against a limited number of aerobic Gram-positive bacteria. |
||
BBF-03328 |
PA-46101 B (130812-34-9) Inquiry |
|
PA-46101 B is a macrolide antibiotic isolated from the culture broth of Streptomyces sp. PA-46101. It is active in vitro against anaerobic Gram-positive and Gram-negative bacteria and also against a limited number of aerobic Gram-positive bacteria. |
||
BBF-03329 | ||
PA-32413-I is a beta-lactam antibiotic produced by Streptomyces clavuigerus PA-32413. It is active against gram-positive and gram-negative bacteria. |
||
BBF-03330 | ||
PB-5266 A is a monobactam antibiotic isolated from the culture filtrate of Cytophaga johnsonae PB-5266. It exhibited weak antibacterial activity against a sensitive mutant of Escherichia coli to beta-lactam antibiotics. |
||
BBF-03331 | ||
PB-5266 B is a monobactam antibiotic isolated from the culture filtrate of Cytophaga johnsonae PB-5266. It exhibited weak antibacterial activity against a sensitive mutant of Escherichia coli to beta-lactam antibiotics. |
||
BBF-03332 | ||
PB-5266 C is a monobactam antibiotic isolated from the culture filtrate of Cytophaga johnsonae PB-5266. It exhibited weak antibacterial activity against a sensitive mutant of Escherichia coli to beta-lactam antibiotics. |
||
BBF-03333 | ||
PD-118576 is an antitumor macrolide antibiotic produced by Streptomyces sp. WP 3913. It exhibits moderate activity against bacteria and fungi. |
||
BBF-03345 | ||
PM-94128 |
||
BBF-03351 | ||
PR 37454 is a polyether antibiotic produced by Streptomyces gypseus DS 27461. It is active against gram-positive bacteria and coccidium. |
||
BBF-03352 | ||
PS-5 is a beta-lactam antibiotic isolated from Streptomyces sp. A271. It is effective against gram-positive and gram-negative bacteria. |
||
BBF-03353 | ||
PS-6 is a beta-lactam antibiotic that can be isolated from Streptomyces cremeus subsp. auratilis, Str. fulvoviridis A-933, Str. olivaceus and Str. flavo-griseus NRRL 8139. It is effective against gram-positive and gram-negative bacteria. |
||
BBF-03354 | ||
PS-7 is a beta-lactam antibiotic that can be isolated from Streptomyces cremeus subsp. auratilis, Str. fulvoviridis A-933, Str. olivaceus and Str. flavo-griseus NRRL 8139. It is effective against gram-positive and gram-negative bacteria. |
||
BBF-03355 | ||
PS-8 is a beta-lactam antibiotic isolated from Streptomyces cremeus subsp. auratilis A 272. It is effective against gram-positive and gram-negative bacteria. |